Hasil Pencarian - Luqing Tong

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    A contemporary molecular view of diffuse gliomas with implications for diagnosis

    A contemporary molecular view of diffuse gliomas with implications for diagnosis oleh Jiabo Li, Xuya Wang, Luqing Tong, Xuejun Yang, Daniel J Brat

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients

    Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients oleh Junyou Wang, Luqing Tong, Gaojun Lin, Hui Wang, Liang Zhang, Xuejun Yang

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Proteomics shows that brain metastases of lung adenocarcinoma overexpress ribosomal proteins in response to gamma knife radiosurgery

    Proteomics shows that brain metastases of lung adenocarcinoma overexpress ribosomal proteins in response to gamma knife radiosurgery oleh Luqing Tong, Ke Ye, Qun Chen, Xiaoxi Wang, Chi Hu, Qingsheng Xu, Lihui Zhou, Renya Zhan, Ying Tong

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4

    Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4 oleh Li Yi, Xingchen Zhou, Tao Li, Peidong Liu, Long Hai, Luqing Tong, Haiwen Ma, Zhennan Tao, Yang Xie, Chen Zhang, Shengping Yu, Xuejun Yang

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway

    IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway oleh Li Yi, Gaochao Guo, Jiabo Li, Xiaoguang Fan, Tao Li, Luqing Tong, Peidong Liu, Xuya Wang, Feng Yuan, Shengping Yu, Qiang Huang, Xuejun Yang

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma

    Sustained localized delivery of immunotherapy to lymph nodes reverses immunosuppression and increases long-term survival in murine glioblastoma oleh John Choi, Ayush Pant, Ravi Medikonda, Young-Hoon Kim, Denis Routkevitch, Laura Saleh, Luqing Tong, Hok Yee Chan, Jessie Nedrow, Christopher Jackson, Christina Jackson, Michael Lim

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma

    Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma oleh John Choi, Ravi Medikonda, Laura Saleh, Timothy Kim, Ayush Pant, Siddhartha Srivastava, Young-Hoon Kim, Christina Jackson, Luqing Tong, Denis Routkevitch, Christopher Jackson, Dimitrios Mathios, Tianna Zhao, Hyerim Cho, Henry Brem, Michael Lim

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling

    Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling oleh Long Hai, Peidong Liu, Shengping Yu, Li Yi, Zhennan Tao, Chen Zhang, Iruni Roshanie Abeysekera, Tao Li, Luqing Tong, Haiwen Ma, Bo Liu, Yang Xie, Xingchen Zhou, Yu Lin, Meng Zhu, Kai Zhang, Bingcheng Ren, Haolang Ming, Yubao Huang, Xuejun  Yang

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: